Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jul 7, 2025; 31(25): 106371
Published online Jul 7, 2025. doi: 10.3748/wjg.v31.i25.106371
Table 3 Significantly altered metabolites in overlap syndrome compared to primary biliary cholangitis
Name
FC
P value
VIP
4-(anilinomethylidene)-3-methyl-4,5-dihydroisoxazol-5-one1.5526960.0007212.639853
2-hydroxy-6-[(8Z,11Z)-pentadeca-8,11,14-trien-1-yl]benzoic acid0.3707920.0038421.818916
Ergosterol peroxide3.1189030.0042432.925869
Cholest-4-en-3-one0.404430.0044991.984777
Propionylcarnitine1.9250510.0046832.61661
Fludrocortisone acetate0.2489680.0052971.854885
N-Methyldioctylamine1.5853330.0058872.162885
Proscillaridin A3.20960.0093322.315147
(+/-)-CP 47,497-C7-hydroxy metabolite0.5447980.0129312.197074
PC (16:1e/22:1)1.7474510.0141322.307943
Octadec-9-ynoic acid0.4403690.0149882.076044
PC (16:1e/22:0)0.480380.0160272.072384
17beta-Trenbolone0.5746120.018042.224429
SM (d14:0/14:1)2.7165970.0186852.053585
alpha-farnesene0.6474870.0225441.773355
Trigonelline0.4211730.0237571.652406
LPE 18:21.5673820.0258361.859335
9-HOTrE0.6161450.0296221.97427
Verapamil hydrochloride0.5632060.0361.803812
Cer-NS (d18:1/16:0)0.5499910.0370821.795717
1,3-dimethyluracil0.4717920.0375511.671353
6-(7-methyloctyl)-1H,3H,4H,6H-furo[3,4-c]furan-1-one1.9710030.0379652.152845
(+/-)5(6)-DiHET0.3668810.0421841.46635
Pilocarpine0.4897330.0433711.922503
PC (3:0/16:4)1.6289910.0448051.521527
Testosterone0.5732490.0469181.426691